局部给药市场规模、份额、成长分析、副产品、给药途径、使用设施和地区 - 按行业预测，2024-2031 年

2022年，全球局部给药市场规模为2,078.5亿美元，从2023年的2,267.6亿美元成长到2031年的4,551.7亿美元，预测期间（2024-2031年）预计复合年增长率为9.1%。

由于干癣、牛皮癣、湿疹和皮肤炎等需要针对性治疗的皮肤病日益流行，全球局部给药市场正在显着增长。对有效治疗方案的需求不断增长，加上面临关节炎和糖尿病溃疡等慢性问题的人口老化，正在加速这些非侵入性输送系统的采用。局部药物传递不仅可以促进疼痛控制和创伤治疗，还可以增强抗衰老征兆的关键活性成分（例如类类视色素A和透明质酸）的传递。此外，人们对美容皮肤科日益增长的兴趣正在刺激局部给药技术的创新，而该市场可能在未来几年继续扩大。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 专利分析
• 监管分析
• 技术分析

局部给药市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 半固态製剂
  • 软膏
  • 奶油
  • 洗剂
  • 凝胶
  • 贴上
• 液体配方
  • 暂停
  • 解决方案
• 固态製剂
  • 粉末
  • 栓剂
• 经皮吸收产品
  • 经皮吸收贴片
  • 经皮固态药物

局部给药市场规模：依给药途径及复合年增长率（2024-2031）

• 市场概况
• 皮肤药物输送
• 眼科药物输送
• 阴道给药
• 直肠给药
• 鼻腔给药

局部给药市场规模：依使用设施及复合年增长率（2024-2031）

• 市场概况
• 家庭护理设置
• 医院/诊所
• 烧烫伤中心
• 其他设施

局部给药市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Glenmark Pharmaceuticals Ltd.（India）
• Galderma（Switzerland）
• Johnson & Johnson Private Limited（US）
• GlaxoSmithKline Plc.（UK）
• Bausch Health Companies Inc.（Canada）
• Hisamitsu Pharmaceuticals Inc.（Japan）
• Cipla（India）
• Bayer AG（Germany）
• Viatris Inc.（Mylan NV）（US）
• 3M（US）
• Merck & Co., Inc.（Germany）
• Crescita Therapeutics Inc.（Canada）
• Novartis International AG（Switzerland）
• Boehringer Ingelheim International GmbH（Germany）
• Pfizer Inc.（US）
• Teva Pharmaceuticals Industries Ltd.（Israel）
• Bristol Myers Squibb（US）
• Lead Chemical Co., Ltd.（Japan）
• Purdue Pharma LP（US）
• Lavipharm（Greece）

结论和建议

Global Topical Drug Delivery Market size was valued at USD 207.85 billion in 2022 and is poised to grow from USD 226.76 billion in 2023 to USD 455.17 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031).

The global topical drug delivery market has seen remarkable growth, driven by the increasing prevalence of skin conditions such as acne, psoriasis, eczema, and dermatitis that necessitate targeted treatment. The rising demand for effective treatment options, coupled with an aging population facing chronic issues like arthritis and diabetic ulcers, has accelerated the adoption of these non-invasive delivery systems. Topical drug delivery not only facilitates pain management and wound healing but also enhances the delivery of active ingredients, such as retinoids and hyaluronic acid, crucial for combating signs of aging. Additionally, the surge in cosmetic dermatology interest has spurred innovation in topical delivery technologies, positioning this market for sustained expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Drug Delivery Market Segmental Analysis

Global Topical Drug Delivery Market is segmented by product, route of administration, facility of use and region. Based on product, the market is segmented into semi-solid formulations, liquid formulations, solid formulations and transdermal products. Based on route of administration, the market is segmented into dermal drug delivery, ophthalmic drug delivery, vaginal drug delivery, rectal drug delivery and nasal drug delivery. Based on facility of use, the market is segmented into homecare settings, hospitals & clinics, burn centers and other facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market is significantly driven by the convenience and non-invasive nature of this method for administering medications. By providing an alternative to injections and oral dosage forms, topical drug delivery appeals to patients who experience anxiety around needles or seek a more comfortable and straightforward treatment process. This ease of use not only improves patient adherence to prescribed therapies but also enhances the overall treatment experience. This method is particularly beneficial for children and individuals with a fear of needles, making topical formulations a favored choice in contemporary healthcare.

Restraints in the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market faces significant restraints primarily due to formulation challenges that arise during the development of stable and effective topical products. Key factors such as drug solubility, stability, and compatibility with excipients complicate the formulation process, necessitating a delicate balance to achieve the desired release profile. These complexities can affect the overall availability and commercial success of topical drug formulations, as they must comply with rigorous quality standards and regulatory requirements while also ensuring that they deliver optimal therapeutic efficacy. Consequently, these formulation challenges pose a barrier to innovation and market growth in the sector.

Market Trends of the Global Topical Drug Delivery Market

The Global Topical Drug Delivery market is witnessing robust growth, propelled by the rising incidence of skin diseases and an ageing population that demands effective treatment options. The shift towards non-invasive drug delivery methodologies enhances patient compliance and accessibility, further fueling market expansion. Innovative technologies like microneedles and nanocarriers are enhancing drug efficacy and penetration, creating new avenues for growth. However, challenges such as high product costs and stringent regulatory hurdles could impede progress. Despite these obstacles, the market remains optimistic, driven by continuous technological advancements and growing awareness of the benefits of topical drug administration.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis

Global Topical Drug Delivery Market Size by Product & CAGR (2024-2031)

• Market Overview
• Semi-Solid Formulations
  • Ointments
  • Creams
  • Lotions
  • Gels
  • Pastes
• Liquid Formulations
  • Suspensions
  • Solutions
• Solid Formulations
  • Powders
  • Suppositories
• Transdermal Products
  • Transdermal Patches
  • Transdermal Semi-Solids

Global Topical Drug Delivery Market Size by Route Of Administration & CAGR (2024-2031)

• Market Overview
• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Vaginal Drug Delivery
• Rectal Drug Delivery
• Nasal Drug Delivery

Global Topical Drug Delivery Market Size by Facility Of Use & CAGR (2024-2031)

• Market Overview
• Homecare Settings
• Hospitals & Clinics
• Burn Centers
• Other Facilities

Global Topical Drug Delivery Market Size & CAGR (2024-2031)

• North America (Product, Route Of Administration, Facility Of Use)
  • USA
  • Canada
• Europe (Product, Route Of Administration, Facility Of Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Route Of Administration, Facility Of Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Route Of Administration, Facility Of Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Route Of Administration, Facility Of Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Glenmark Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Private Limited (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hisamitsu Pharmaceuticals Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris Inc. (Mylan N.V.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crescita Therapeutics Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lead Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma L.P. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lavipharm (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations